PubMed

Deletion of cd39/entpd1 results in hepatic insulin resistance.

Enjyoji K, Kotani K, Thukral C, Blumel B, Sun X, Wu Y, Imai M, Friedman D, Csizmadia E, Bleibel W, Kahn BB, Robson SC.

Diabetes. 2008 Sep;57(9):2311-20. Epub 2008 Jun 20.PMID: 18567823 [PubMed - indexed for MEDLINE]Related articlesFree article

Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice.

Jackson SW, Hoshi T, Wu Y, Sun X, Enjyoji K, Cszimadia E, Sundberg C, Robson SC.

Am J Pathol. 2007 Oct;171(4):1395-404. Epub 2007 Sep 6.PMID: 17823293 [PubMed - indexed for MEDLINE]Related articlesFree article

Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.

Beldi G, Wu Y, Banz Y, Nowak M, Miller L, Enjyoji K, Haschemi A, Yegutkin GG, Candinas D, Exley M, Robson SC.

Hepatology. 2008 Sep;48(3):841-52. Erratum in: Hepatology. 2009 Jul;50(1):331. PMID: 18752325 [PubMed - indexed for MEDLINE]Related articles

Regulated catalysis of extracellular nucleotides by vascular CD39/ENTPD1 is required for liver regeneration.

Beldi G, Wu Y, Sun X, Imai M, Enjyoji K, Csizmadia E, Candinas D, Erb L, Robson SC.

Gastroenterology. 2008 Nov;135(5):1751-60. Epub 2008 Jul 31.PMID: 18804472 [PubMed - indexed for MEDLINE]Related articles

Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice.

Künzli BM, Nuhn P, Enjyoji K, Banz Y, Smith RN, Csizmadia E, Schuppan D, Berberat PO, Friess H, Robson SC.

Gastroenterology. 2008 Jan;134(1):292-305. Epub 2007 Oct 25.PMID: 18036594 [PubMed - indexed for MEDLINE]Related articlesFree article

The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathy.

Friedman DJ, Rennke HG, Csizmadia E, Enjyoji K, Robson SC.

Diabetes. 2007 Sep;56(9):2371-9. Epub 2007 May 1.PMID: 17473221 [PubMed - indexed for MEDLINE]Related articlesFree article

Western diet modulates insulin signaling, c-Jun N-terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion.

Prada PO, Zecchin HG, Gasparetti AL, Torsoni MA, Ueno M, Hirata AE, Corezola do Amaral ME, Höer NF, Boschero AC, Saad MJ.

Endocrinology. 2005 Mar;146(3):1576-87. Epub 2004 Dec 9.PMID: 15591151 [PubMed - indexed for MEDLINE]Related articlesFree article

Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.

Guckelberger O, Sun XF, Sévigny J, Imai M, Kaczmarek E, Enjyoji K, Kruskal JB, Robson SC.

Thromb Haemost. 2004 Mar;91(3):576-86.PMID: 14983235 [PubMed - indexed for MEDLINE]Related articles

Preservation of cochlear function in Cd39 deficient mice.

Vlajkovic SM, Housley GD, Thorne PR, Gupta R, Enjyoji K, Cowan PJ, Charles Liberman M, Robson SC.

Hear Res. 2009 Jul;253(1-2):77-82. Epub 2009 Mar 25.PMID: 19327391 [PubMed - indexed for MEDLINE]Related articles

Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues.

Wang H, Knaub LA, Jensen DR, Young Jung D, Hong EG, Ko HJ, Coates AM, Goldberg IJ, de la Houssaye BA, Janssen RC, McCurdy CE, Rahman SM, Soo Choi C, Shulman GI, Kim JK, Friedman JE, Eckel RH.

Diabetes. 2009 Jan;58(1):116-24. Epub 2008 Oct 24.PMID: 18952837 [PubMed - indexed for MEDLINE]Related articlesFree article

Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors.

Schaefer U, Machida T, Broekman MJ, Marcus AJ, Levi R.

J Pharmacol Exp Ther. 2007 Sep;322(3):1269-77. Epub 2007 Jun 12.PMID: 17565006 [PubMed - indexed for MEDLINE]Related articlesFree article

Vascular stasis, intestinal hemorrhage, and heightened vascular permeability complicate acute portal hypertension in cd39-null mice.

Sun X, Cárdenas A, Wu Y, Enjyoji K, Robson SC.

Am J Physiol Gastrointest Liver Physiol. 2009 Aug;297(2):G306-11. Epub 2009 Jun 11.PMID: 19520738 [PubMed - indexed for MEDLINE]Related articles

CD39 is incorporated into plasma microparticles where it maintains functional properties and impacts endothelial activation.

Banz Y, Beldi G, Wu Y, Atkinson B, Usheva A, Robson SC.

Br J Haematol. 2008 Aug;142(4):627-37. Epub 2008 Jun 5.PMID: 18537971 [PubMed - indexed for MEDLINE]Related articles

The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism.

Beldi G, Enjyoji K, Wu Y, Miller L, Banz Y, Sun X, Robson SC.

Front Biosci. 2008 Jan 1;13:2588-603. Review.PMID: 17981736 [PubMed - indexed for MEDLINE]Related articles

SH2B1 enhances insulin sensitivity by both stimulating the insulin receptor and inhibiting tyrosine dephosphorylation of insulin receptor substrate proteins.

Morris DL, Cho KW, Zhou Y, Rui L.

Diabetes. 2009 Sep;58(9):2039-47. Epub 2009 Jun 19.PMID: 19542202 [PubMed - indexed for MEDLINE]Related articles

Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance.

Duan C, Yang H, White MF, Rui L.

Mol Cell Biol. 2004 Sep;24(17):7435-43.PMID: 15314154 [PubMed - indexed for MEDLINE]Related articlesFree article

Disordered cellular migration and angiogenesis in cd39-null mice.

Goepfert C, Sundberg C, Sévigny J, Enjyoji K, Hoshi T, Csizmadia E, Robson S.

Circulation. 2001 Dec 18;104(25):3109-15.PMID: 11748109 [PubMed - indexed for MEDLINE]Related articlesFree article

Infliximab restores glucose homeostasis in an animal model of diet-induced obesity and diabetes.

Araújo EP, De Souza CT, Ueno M, Cintra DE, Bertolo MB, Carvalheira JB, Saad MJ, Velloso LA.

Endocrinology. 2007 Dec;148(12):5991-7. Epub 2007 Aug 30.PMID: 17761768 [PubMed - indexed for MEDLINE]Related articlesFree article

Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling.

Sharfi H, Eldar-Finkelman H.

Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E307-15. Epub 2007 Nov 20.PMID: 18029441 [PubMed - indexed for MEDLINE]Related articlesFree article

Vascular smooth muscle cell expression of ectonucleotidase CD39 (ENTPD1) is required for neointimal formation in mice.

Behdad A, Sun X, Khalpey Z, Enjyoji K, Wink M, Wu Y, Usheva A, Robson SC.

Purinergic Signal. 2009 Sep;5(3):335-42. Epub 2009 Mar 24.PMID: 19308674 [PubMed - in process]Related articlesFree article